Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2009
06/10/2009CN100497366C Process for extracting cyclic adenosine monophosphate (cAMP) from Chinese date
06/09/2009US7544794 Method for sequencing DNA and RNA by synthesis
06/09/2009CA2352229C Glyceryl nucleotides, method for the production thereof and their use
06/04/2009WO2009069291A1 Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke
06/04/2009WO2001055301A3 Nucleic acids, proteins, and antibodies
06/04/2009CA2706432A1 Antiviral nucleoside compounds
06/03/2009CN101448846A Method for purification of cytidinediphosphoric choline
06/03/2009CN100494212C Indolopyrrolocabazole derivative and antitumor agent
06/02/2009US7541448 Oligonucleotides containing molecular rods
06/02/2009US7541444 Invention relates to nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, and which molecules may be used in reactions where blocked nucleotide or nucleoside molecules are required, such as in sequencing reactions, polynucleotide synthesis
06/02/2009CA2534024C Novel compounds having inhibitory activity against sodium-dependant transporter
05/2009
05/28/2009WO2009067409A1 2',4'-substituted nucleosides as antiviral agents
05/28/2009WO2009067035A2 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
05/28/2009WO2009066447A1 Light-responsive artificial nucleotide having photo-crosslinking ability
05/28/2009WO2009066298A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
05/28/2009WO2008043426A3 Components and method for enzymatic synthesis of nucleic acids
05/28/2009US20090137791 solid phase synthesis of oligonucleotides and peptides on silicon chips, multiwell plates, glass beads
05/28/2009US20090137521 Certain Compounds, Compositions and Methods
05/28/2009US20090137520 Cardiovascular disorders such as tachycardia and atrial flutter, angina, myocardial infarction, diabetes, obesity, ischemia; for example 4-[N-({9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-hydroxymethyl)tetrahydrofuran-2-yl]-6-(cyclopentylamino)purin-2-yl}methyl)carbamoyl]benzenesulfonic acid
05/28/2009US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection
05/28/2009US20090136940 Phosphoramidite nucleoside analogs
05/28/2009CA2706327A1 2',4'-substituted nucleosides as antiviral agents
05/28/2009CA2706222A1 Light-responsive artificial nucleotide having photo-crosslinking ability
05/27/2009EP2061316A2 Azole nucleosides and use as inhibitors of rna and dna varial polymerases
05/27/2009EP1594987B1 Nucleic acid sequencing methods, kits and reagents
05/27/2009EP1141409B2 A kit and methods for nucleic acid sequencing of single molecules by polymerase synthesis
05/27/2009EP1121371B1 Nucleotide compounds including a rigid linker
05/27/2009CN101443332A Anti-viral pyrimidine nucleoside derivatives
05/27/2009CN101440111A Anti-tumor compound and preparation thereof
05/27/2009CN100490818C Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides
05/26/2009US7537751 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection
05/26/2009CA2337225C Novel antibacterial compounds
05/21/2009US20090131652 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
05/21/2009US20090131651 Synthesis of 2-substituted adenosines
05/21/2009US20090131370 Novel Nucleoside Derivatives
05/21/2009US20090131342 Nitrosated and/or nitrosylated compounds, compositions and methods of use
05/21/2009US20090130214 Gemcitabine derivatives nanoparticles
05/20/2009CN101437935A Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake
05/20/2009CN101437397A Nucleotide and oligonucleotide prodrugs
05/20/2009CN101434628A Process for synthesizing L-beta-5-methyl uracil riboside
05/20/2009CN101434627A 2'-fluoro-4'-substituted nucleoside analogue, synthetic method and use thereof
05/20/2009CN100488978C A continuous extraction method of effective ingredients from fruitbodies of Cordyceps militaris
05/20/2009CN100488977C Technology of producing cytidine by chemical synthesizing process
05/20/2009CN100488516C Use of compound in preparing medicament for pancreatic cancer treatment
05/19/2009US7534771 Tricyclic-nucleoside prodrugs for treating viral infections
05/14/2009WO2009061941A2 Baseless nucleotide analogues and uses thereof
05/14/2009WO2009061781A1 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
05/14/2009WO2009060063A1 Anthelmintic combination
05/14/2009WO2008088779A3 Solid state forms of 5-azacytidine and processes for preparation thereof
05/14/2009WO2006012624A3 Mechanism-based crosslinkers
05/14/2009US20090124797 Novel synthesis of beta-nucleosides
05/14/2009US20090124796 Nucleobase Having Perfluoroalkyl Group and Process for Producing the Same
05/14/2009US20090123922 Bead Bound Combinatorial Oligonucleoside Phosphorothioate And Phosphorodithioate Aptamer Libraries
05/14/2009US20090123388 Prodrugs of Short-Chain Fatty Acids and Treatment Methods
05/14/2009CA2705092A1 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
05/13/2009EP2057175A2 Nucleotide analogs
05/13/2009EP1560838B1 Labelled nucleotides
05/13/2009EP1495325B1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof
05/13/2009EP1317464B1 Fluorescent nucleobase conjugates having anionic linkers
05/13/2009EP1117838B1 A method for analyzing polynucleotides
05/13/2009CN101429262A Porous resin particle having hydroxy group or primary amino group and production method thereof
05/13/2009CN101429261A Production method of porous resin bead
05/13/2009CN101429223A Process for producing novel growth regulator for pig
05/13/2009CN101429215A Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
05/13/2009CN100486987C Antivira and antitumor deoxyoligonucleotide containing CpG single strand
05/12/2009US7531525 Administering the salt, which is a P2Y purinergic receptor agonist that is hydrolysis-resistant to stimulate the removal of pathological fluid accumulation
05/12/2009US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies
05/12/2009CA2312099C New fluorescent cyanine labels containing a sulfamido linker arm
05/07/2009WO2009029888A3 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
05/07/2009US20090118491 Stable salt of 3'-phosphoadenosine 5'-phosphosulfate for use as enhanced sulfate donor in pharmaceutical products or health foods
05/07/2009US20090118481 High Affinity Nucleic Acid Ligands To Lectins
05/07/2009US20090118224 Agent against psychosocial stresses
05/07/2009US20090118223 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives
05/07/2009US20090118222 Novel pyrimidine nucleoside compound or its salt
05/07/2009US20090118221 Method of treating arrhythmias
05/07/2009US20090118220 Substituted adenines and the uses thereof
05/07/2009US20090117204 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use
05/07/2009US20090117041 Radiologic Agents for Monitoring Alzheimer's Disease Progression and Evaluating a Response to Therapy and Processes for the Preparation of Such Agents
05/06/2009EP2055711A1 Use of squalenic acid for the formulation of an active principle in nanoparticle state
05/06/2009EP2054415A1 Adenosine receptor antagonists
05/06/2009EP1572711B1 Anhydrous crystalline azido cytosine hemisulfate derivative
05/06/2009EP1212457B1 Uv excitable fluorescent energy transfer dyes
05/06/2009CN101423540A Cytarabin 5'-O-L-valine ester and pharmaceutically acceptable salt as well as preparation and application thereof
05/06/2009CN100484950C Purification of 2-iodo-6-chloro-9-beta(2',3',5'-trioxyacetyl-D-furanose)purine
05/06/2009CN100484949C Nucleoside phosphoramidite used in RNA oligo-nucleotide synthesis and its synthesizing method
05/05/2009US7528247 Process for preparing purine nucleosides
05/05/2009US7528115 Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines
04/2009
04/30/2009WO2009053654A2 Gemcitabine phosphoester prodrugs as anticancer agents
04/30/2009WO2008109080A3 Nucleoside based proliferation imaging markers
04/30/2009WO2007056213A3 Drug-eluting stents coated with p2y12 receptor antagonist compound
04/30/2009US20090111979 Modified 5'- phosphonate azidothymidine - potential anti-viral preparations
04/30/2009US20090110671 Agent for enhanching the production of collagen and it's use
04/29/2009EP2053054A1 Method for introducing nucleic-acid-protecting group
04/29/2009EP1425022A4 Mutagenic nucleoside analogs for the treatment of viral disease
04/29/2009CN101421289A Method for removal of nucleic acid-protecting group
04/29/2009CN101420959A Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine A2A receptor agonists
04/29/2009CN101418028A Synthesis of beta-l-2-deoxy nucleosides
04/29/2009CN100482236C Beta-L-2'-dioxidition-nucleoside for treating hepatitis B
04/28/2009US7524942 For analysis of ligated RNA
04/28/2009US7524825 Tricyclic-nucleoside compounds for treating viral infections
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 201